Long-term GnRH agonist therapy before in vitro fertilization (IVF) for improving fertility outcomes in women with endometriosis

Sharifah Halimah Jaafar, Hassan Sallam, Aydın Arıcı, Juan A. García-Velasco, Ahmed M Abou-Setta
In: Cochrane Database of Systematic Reviews · 2019 · doi:10.1002/14651858.cd013240 · W4239059957
article OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This protocol outlines a review to assess the effectiveness and safety of long-term GnRH agonist therapy prior to IVF for women with endometriosis compared to other pretreatment options.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the effectiveness and safety of long‐term GnRH agonist therapy versus no pretreatment or other pretreatment modalities, (such as long‐term continuous COC or surgical therapy), before standard IVF or ICSI in women with endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (34)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK